Sort by
Items per page

Send to

Choose Destination

Best matches for resveratrol colon cancer:

The Role of Resveratrol in Cancer Therapy. Ko JH et al. Int J Mol Sci. (2017)

Resveratrol reverses the Warburg effect by targeting the pyruvate dehydrogenase complex in colon cancer cells. Saunier E et al. Sci Rep. (2017)

Evaluation of <sup>99m</sup> Tc-resveratrol as a colon cancer targeting probe. Kamal R et al. Eur J Cancer Care (Engl). (2017)

Search results

Items: 1 to 20 of 266


Molecular Mechanisms of Curcumin and Its Analogs in Colon Cancer Prevention and Treatment.

Selvam C, Prabu SL, Jordan BC, Purushothaman Y, Umamaheswari A, Hosseini Zare MS, Thilagavathi R.

Life Sci. 2019 Nov 5:117032. doi: 10.1016/j.lfs.2019.117032. [Epub ahead of print] Review.


3,5,4'-trimethoxy-trans-stilbene loaded PEG-PE micelles for the treatment of colon cancer.

Wu JY, Li YJ, Liu XY, Cai JX, Hu XB, Wang JM, Tang TT, Xiang DX.

Int J Nanomedicine. 2019 Sep 12;14:7489-7502. doi: 10.2147/IJN.S221625. eCollection 2019.


Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial‑ mesenchymal transition via the AKT/GSK‑3β/Snail signaling pathway.

Yuan L, Zhou M, Huang D, Wasan HS, Zhang K, Sun L, Huang H, Ma S, Shen M, Ruan S.

Mol Med Rep. 2019 Sep;20(3):2783-2795. doi: 10.3892/mmr.2019.10528. Epub 2019 Jul 25.


P-Glycoprotein 1 Affects Chemoactivities of Resveratrol against Human Colorectal Cancer Cells.

Aires V, Colin DJ, Doreau A, Di Pietro A, Heydel JM, Artur Y, Latruffe N, Delmas D.

Nutrients. 2019 Sep 4;11(9). pii: E2098. doi: 10.3390/nu11092098.


Anti-cancerous Effect of Rutin Against HPV-C33A Cervical Cancer Cells via G0/G1 Cell Cycle Arrest and Apoptotic Induction

Khan F, Pandey P, Upadhyay TK, Jafri A, Jha NK, Mishra R, Singh V.

Endocr Metab Immune Disord Drug Targets. 2019 Aug 6. doi: 10.2174/1871530319666190806122257. [Epub ahead of print]


Anti-Irritant and Anti-Inflammatory Effects of DHA Encapsulated in Resveratrol-Based Solid Lipid Nanoparticles in Human Keratinocytes.

Serini S, Cassano R, Facchinetti E, Amendola G, Trombino S, Calviello G.

Nutrients. 2019 Jun 21;11(6). pii: E1400. doi: 10.3390/nu11061400.


Effects of As2O3 and Resveratrol on the Proliferation and Apoptosis of Colon Cancer Cells and the hERG-mediated Potential Mechanisms.

Yan C, Li F, Zhang Y, Li Y, Li M, Wang F, Zhang G, Li Y, Li B, Zhao X.

Curr Pharm Des. 2019;25(12):1385-1391. doi: 10.2174/1381612817666190619123610.


Rbfox2 dissociation from stress granules suppresses cancer progression.

Choi S, Sa M, Cho N, Kim KK, Park SH.

Exp Mol Med. 2019 Apr 26;51(4):49. doi: 10.1038/s12276-019-0246-y.


Advances in phytochemical delivery systems for improved anticancer activity.

Lagoa R, Silva J, Rodrigues JR, Bishayee A.

Biotechnol Adv. 2019 Apr 9. pii: S0734-9750(19)30063-1. doi: 10.1016/j.biotechadv.2019.04.004. [Epub ahead of print] Review.


Curcumin: Total-Scale Analysis of the Scientific Literature.

Yeung AWK, Horbańczuk M, Tzvetkov NT, Mocan A, Carradori S, Maggi F, Marchewka J, Sut S, Dall'Acqua S, Gan RY, Tancheva LP, Polgar T, Berindan-Neagoe I, Pirgozliev V, Šmejkal K, Atanasov AG.

Molecules. 2019 Apr 9;24(7). pii: E1393. doi: 10.3390/molecules24071393.


Potential of utilization of albumin as a delivery module in cancer model.

Jin Z, Li JS, Tang DN.

J BUON. 2019 Jan-Feb;24(1):347-353.


Metabolism of Stilbenoids by Human Faecal Microbiota.

Jarosova V, Vesely O, Marsik P, Jaimes JD, Smejkal K, Kloucek P, Havlik J.

Molecules. 2019 Mar 23;24(6). pii: E1155. doi: 10.3390/molecules24061155.


Resveratrol induces p53 in colorectal cancer through SET7/9.

Liu Z, Wu X, Lv J, Sun H, Zhou F.

Oncol Lett. 2019 Apr;17(4):3783-3789. doi: 10.3892/ol.2019.10034. Epub 2019 Feb 13.


Mkp-1 is required for chemopreventive activity of butylated hydroxyanisole and resveratrol against colitis-associated colon tumorigenesis.

Zheng Z, Chen Y, Huang J, Deng H, Tang X, Wang XJ.

Food Chem Toxicol. 2019 May;127:72-80. doi: 10.1016/j.fct.2019.02.044. Epub 2019 Mar 4.


Treatment of cancer stem cells from human colon adenocarcinoma cell line HT-29 with resveratrol and sulindac induced mesenchymal-endothelial transition rate.

Pouyafar A, Rezabakhsh A, Rahbarghazi R, Heydarabad MZ, Shokrollahi E, Sokullu E, Khaksar M, Nourazarian A, Avci ÇB.

Cell Tissue Res. 2019 Jun;376(3):377-388. doi: 10.1007/s00441-019-02998-9. Epub 2019 Feb 13.


Resveratrol mediated cancer cell apoptosis, and modulation of multidrug resistance proteins and metabolic enzymes.

El-Readi MZ, Eid S, Abdelghany AA, Al-Amoudi HS, Efferth T, Wink M.

Phytomedicine. 2019 Mar 1;55:269-281. doi: 10.1016/j.phymed.2018.06.046. Epub 2018 Jun 28.


[Emerging Actions of Pterostilebene on Cancer Research].

Zhang X, Zhang J, Xu L, Ma Z, Di S, Gao Y, Li X, Yan X, Zhang H.

Zhongguo Fei Ai Za Zhi. 2018 Dec 20;21(12):931-936. doi: 10.3779/j.issn.1009-3419.2018.12.01. Review. Chinese.


Phosphodiesterase 4B is an effective therapeutic target in colorectal cancer.

Kim DU, Kwak B, Kim SW.

Biochem Biophys Res Commun. 2019 Jan 15;508(3):825-831. doi: 10.1016/j.bbrc.2018.12.004. Epub 2018 Dec 7.


Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway.

Li D, Wang G, Jin G, Yao K, Zhao Z, Bie L, Guo Y, Li N, Deng W, Chen X, Chen B, Liu Y, Luo S, Guo Z.

Int J Mol Med. 2019 Jan;43(1):630-640. doi: 10.3892/ijmm.2018.3969. Epub 2018 Nov 1.


Resveratrol: Twenty Years of Growth, Development and Controversy.

Pezzuto JM.

Biomol Ther (Seoul). 2019 Jan 1;27(1):1-14. doi: 10.4062/biomolther.2018.176. Review.

Supplemental Content

Loading ...
Support Center